Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung and Pleural Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04131231
What this trial is testing

Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion

Who this might be right for
Lung CancerBreast CancerMalignant Pleural Effusion
Peking Union Medical College 248
Testing effectiveness (Phase 2)Study completedNCT00787410
What this trial is testing

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

Who this might be right for
Mesothelioma
AstraZeneca 23
Not applicableStudy completedNCT02958683
What this trial is testing

Chest Wall Motion Analysis in Disease

Who this might be right for
MesotheliomaLung NeoplasmsSurgery+5 more
Heart of England NHS Trust 400
Testing effectiveness (Phase 2)Study completedNCT00343291
What this trial is testing

Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 121
Testing effectiveness (Phase 2)Study completedNCT05136677
What this trial is testing

Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 102
Testing effectiveness (Phase 2)Ended earlyNCT00859495
What this trial is testing

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Columbia University 9
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Not applicableStudy completedNCT02107001
What this trial is testing

Lung Ultrasound in Pleuritic Chest Pain

Who this might be right for
Community Acquired PneumoniaPleuritisPulmonary Embolism+1 more
University of Milan 400
Not applicableLooking for participantsNCT06946498
What this trial is testing

First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.

Who this might be right for
Suspected Malignant Lung NeoplasmPleural EffusionPleural Effusion, Malignant+1 more
National and Kapodistrian University of Athens 100
Not applicableStudy completedNCT04843007
What this trial is testing

Alvopem® (Pemetrexed) Safety Assessment

Who this might be right for
Non Small Cell Lung CancerMalignant Pleural Mesothelioma
NanoAlvand 199
Not applicableStudy completedNCT05594485
What this trial is testing

Retrospective Study of Carebot AI CXR Performance in Preclinical Practice

Who this might be right for
Artificial IntelligenceLung DiseasesPneumothorax+9 more
Carebot s.r.o. 127
Early research (Phase 1)Ended earlyNCT01313429
What this trial is testing

Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum

Who this might be right for
SarcomaMelanomaEpithelial Malignancies+1 more
National Cancer Institute (NCI) 19
Not applicableUnknownNCT03290183
What this trial is testing

Confocal Laser Endomicroscopy in Pleural Malignancies

Who this might be right for
Pleural Malignant MesotheliomaThymomaPleural Diseases
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Testing effectiveness (Phase 2)UnknownNCT05429866
What this trial is testing

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Who this might be right for
Breast CancerMelanomaNon Small Cell Lung Cancer+10 more
Jules Bordet Institute 441
Testing effectiveness (Phase 2)Study completedNCT05455424
What this trial is testing

Niraparib Efficacy in Patient With Unresectable Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University Hospital Southampton NHS Foundation Trust 88
Testing effectiveness (Phase 2)Study completedNCT05380713
What this trial is testing

......SMARTEST Trial......

Who this might be right for
Mesothelioma, Malignant
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Study completedNCT00039182
What this trial is testing

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 55
Not applicableLooking for participantsNCT07807696
What this trial is testing

Olive Oil Before Lung Cancer Surgery to Prevent Chylothorax

Who this might be right for
Lung CancerChylothorax
Fudan University 1,036
Testing effectiveness (Phase 2)Study completedNCT00003723
What this trial is testing

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)UnknownNCT01655888
What this trial is testing

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese 29
Next Page